Douglas A. Jabs, M.D., M.B.A. is Professor of Epidemiology and Director of the Center for Clinical Trials and Evidence Synthesis at the Johns Hopkins Bloomberg School of Public Health (JHBSPH) and Professor of Ophthalmology at The Wilmer Eye Institute, the Johns Hopkins School of Medicine (JHSOM). He received an M.D. from the JHSOM and an M.B.A. from the Johns Hopkins University. His training includes an internship in Internal Medicine at the New York Hospital-Cornell Medical Center, residency in Internal Medicine at the Johns Hopkins Hospital, residency in Ophthalmology at the Wilmer Eye Institute, and a fellowship in Rheumatology at The Johns Hopkins Medical Institutions. In 1984, he joined the JHSOM faculty as Director of the Uveitis Service and was promoted to Professor of Ophthalmology and Medicine in 1993. He became Chairman of the Department of Ophthalmology at the Icahn School of Medicine at Mount Sinai in 2007, where he also was the CEO of the Mount Sinai Doctors Faculty Practice. In 2019 he was named Director of the Center for Clinical Trials and Evidence Synthesis at the Bloomberg School of Public Health. Dr. Jabs is an accomplished clinician scientist, has held continuous NIH funding for over 30 years, and has chaired 9 NIH-funded, multicenter clinical trials, including the MUST Trial, the POINT Trial, and the ADVISE Trial. He chairs the Standardization of Uveitis Nomenclature (SUN) Working Group, which recently published classification criteria for 25 of the most common uveitides. He has authored over 365 publications and 48 book chapters.